Amgen Inc (AMGN)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 7,258,000 6,218,000 6,192,000 6,967,000 7,897,000 7,878,000 7,780,000 7,272,000 6,480,000 7,532,000 7,987,000 6,639,000 7,639,000 7,343,000 7,418,000 8,913,000 9,139,000 9,179,000 9,202,000 9,557,000
Total assets US$ in thousands 91,839,000 90,883,000 90,907,000 92,980,000 97,154,000 90,534,000 90,269,000 88,720,000 65,121,000 63,700,000 59,294,000 59,196,000 61,165,000 64,993,000 59,773,000 62,539,000 62,948,000 64,637,000 65,011,000 61,669,000
Operating ROA 7.90% 6.84% 6.81% 7.49% 8.13% 8.70% 8.62% 8.20% 9.95% 11.82% 13.47% 11.22% 12.49% 11.30% 12.41% 14.25% 14.52% 14.20% 14.15% 15.50%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $7,258,000K ÷ $91,839,000K
= 7.90%

Operating Return on Assets (Operating ROA) is a key financial ratio that measures a company's efficiency in generating operating profits relative to its total assets. Analyzing the trend of Amgen Inc's Operating ROA from March 31, 2020, to December 31, 2024, provides insights into the company's operational performance.

The Operating ROA of Amgen Inc has fluctuated over the period, starting at a relatively high level of 15.50% in March 2020, and then gradually decreasing to 6.81% by June 30, 2024. This declining trend suggests a decrease in the company's ability to generate operating income from its total assets.

There are notable fluctuations in the Operating ROA during this period, indicating potential changes in Amgen Inc's operational efficiency and profitability. Notable points include an increase in Operating ROA from June 2021 to September 2021, followed by a declining trend until December 2024.

The decline in Operating ROA could be attributed to various factors such as increased operating expenses, lower revenue generation, or inefficient asset utilization. Investors and analysts may need to further investigate the reasons behind the declining trend in Amgen Inc's Operating ROA to assess the company's financial health and operational effectiveness.